Lisinopril
- Strength
- 40 mg/1
- Form
- Tablet
- Class
- Angiotensin Converting Enzyme Inhibitor
XLCare Pharmaceuticals Inc.
Listed by NCS HealthCare of KY, LLC dba Vangard Labs
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Angiotensin Converting Enzyme Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 0615-8252 |
| FDA application | ANDA077321 |
| RxNorm concept | 197884 |
| Package sizes listed | 2 |
| Marketed since | January 2006 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
XLCare Pharmaceuticals Inc.
Exelan Pharmaceuticals Inc.
Actavis Pharma, Inc.
Actavis Pharma, Inc.
NCS HealthCare of KY, LLC dba Vangard Labs
Heritage Pharmaceuticals Inc. d/b/a Avet Pharma…
Camber Pharmaceuticals, Inc.
QPharma Inc
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.